Search results
Results from the WOW.Com Content Network
Ménière's disease (MD) is a disease of the inner ear that is characterized by potentially severe and incapacitating episodes of vertigo, tinnitus, hearing loss, and a feeling of fullness in the ear. [3] [4] Typically, only one ear is affected initially, but over time, both ears may become involved. [3]
Dizziness affects approximately 20–40% of people at some point in time, while about 7.5–10% have vertigo. [3] About 5% have vertigo in a given year. [10] It becomes more common with age and affects women two to three times more often than men. [10] Vertigo accounts for about 2–3% of emergency department visits in the developed world. [10]
Ménière's disease – causes sensorineural hearing loss in the low frequency range (125 Hz to 1000 Hz). Ménière's disease is characterized by sudden attacks of vertigo, lasting minutes to hours preceded by tinnitus, aural fullness, and fluctuating hearing loss. It is relatively rare and commonly over diagnosed.
Lead time bias happens when survival time appears longer because diagnosis was done earlier (for instance, by screening), irrespective of whether the patient lived longer. Lead time is the duration of time between the detection of a disease (by screening or based on new experimental criteria) and its usual clinical presentation and diagnosis ...
Prosper Menière (18 June 1799 – 7 February 1862) was a French medical doctor who first identified that the inner ear could be the source of a condition combining vertigo, hearing loss and tinnitus, [1] which is now known as Ménière's disease.
The superior semicircular canal dehiscence syndrome (SSCDS) is a set of hearing and balance symptoms that a rare disease/disorder of the inner ear's superior semicircular canal/duct induces. [ 3 ] [ 4 ] [ 5 ] The symptoms are caused by a thinning or complete absence of the part of the temporal bone overlying the superior semicircular canal of ...
Hearing Health Foundation (HHF) is a 501(c)(3) nonprofit organization. In 2011, the Deafness Research Foundation changed its name to Hearing Health Foundation. [3]HHF was founded as the Deafness Research Foundation in 1958, by Collette Ramsey Baker, a woman who lived with a substantial hearing loss.
Betahistine, sold under the brand name Serc among others, is an anti-vertigo medication.It is commonly prescribed for balance disorders or to alleviate vertigo symptoms.It was first registered in Europe in 1970 for the treatment of Ménière's disease, but current evidence does not support its efficacy in treating it.